A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer

NCT01550848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Abraxane and Gemcitabine

Sponsor

Fudan University